158 related articles for article (PubMed ID: 35683561)
1. Surgical Outcomes and Prognostic Factors of G3 Pancreatic Neuroendocrine Carcinomas: A Consecutive Analysis Based on Previous Study Results.
Luo X; Yang M; Tian B; Liu X; Duan K; Zhang Y
J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683561
[TBL] [Abstract][Full Text] [Related]
2. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
[TBL] [Abstract][Full Text] [Related]
3. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
[TBL] [Abstract][Full Text] [Related]
4. Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on Cancer 8th tumor-node-metastasis staging systems.
Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
Eur J Surg Oncol; 2019 Jun; 45(6):1054-1060. PubMed ID: 30661921
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
[TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
8. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
[TBL] [Abstract][Full Text] [Related]
9. Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors.
Yang M; Zeng L; Hou S; Tian B; Jin S; Zhang Y
J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142900
[TBL] [Abstract][Full Text] [Related]
10. Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.
Yang M; Ke NW; Zhang Y; Zeng L; Tan CL; Zhang H; Mai G; Tian BL; Liu XB
Medicine (Baltimore); 2015 Dec; 94(48):e2156. PubMed ID: 26632896
[TBL] [Abstract][Full Text] [Related]
11. Concordance Between the Ki-67 Index Cutoff Value of 55% and Differentiation in Neuroendocrine Tumor and Neuroendocrine Carcinoma in Grade 3 Pancreatic Neuroendocrine Neoplasms.
Shi H; Chen L; Zhang Q; Lin Y; Jiang C; Yao H; Hou X; Chen M; Lin R; Chen J
Pancreas; 2020; 49(10):1378-1382. PubMed ID: 33122528
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology.
Han X; Xu X; Ma H; Ji Y; Wang D; Kuang T; Wu W; Song B; Li G; Jin G; Lou W
Endocr Connect; 2018 Feb; 7(2):355-363. PubMed ID: 29472376
[TBL] [Abstract][Full Text] [Related]
13. Value of computed tomography evaluation in pathologic classification and prognosis prediction of gastric neuroendocrine tumors.
Yan S; Liu T; Li Y; Zhu Y; Jiang J; Jiang L; Zhao H
Ann Transl Med; 2019 Oct; 7(20):545. PubMed ID: 31807527
[TBL] [Abstract][Full Text] [Related]
14. Clinical Features and Long-Term Survival of Metastatic Hepatic Neuroendocrine Neoplasms Secondary to Gastroenteropancreatic Site: An Analysis by Applying the Grading Classification.
Yang M; Zeng L; Hou SZ; Ke NW; Tian BL; Liu XB; Xiang B; Zhang Y
J Oncol; 2020; 2020():6572398. PubMed ID: 33014053
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastases and recurrence in pancreatic neuroendocrine neoplasms.
Nießen A; Schimmack S; Lewosinska M; Hinz U; Bechtiger FA; Hackert T; Büchler MW; Strobel O
Surgery; 2022 Dec; 172(6):1791-1799. PubMed ID: 36180252
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes and prognostic factors of resected pancreatic neuroendocrine neoplasms: A single-center experience in China.
Jin K; Luo G; Xu J; Zhang B; Liu C; Ji S; Liu L; Long J; Ni Q; Yu X
Oncol Lett; 2017 May; 13(5):3163-3168. PubMed ID: 28521422
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
18. Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia.
Abdelmalak R; Lythgoe MP; Evans J; Flynn M; Waters J; Webb A; Pinato DJ; Sharma R
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439386
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms.
Gao C; Fan Z; Yang J; Shi M; Li Y; Zhan H
Pancreatology; 2023 Mar; 23(2):204-212. PubMed ID: 36710224
[TBL] [Abstract][Full Text] [Related]
20. Outcome of surgery for pancreatic neuroendocrine neoplasms.
Fischer L; Bergmann F; Schimmack S; Hinz U; Prieß S; Müller-Stich BP; Werner J; Hackert T; Büchler MW
Br J Surg; 2014 Oct; 101(11):1405-12. PubMed ID: 25132004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
